Alvaro Arjona
@alarjosan
Oncologic, pancreatic and transplant surgeon. PMP researcher. European board surgical oncology. Coordinator of GECOP. Runner.
ID: 717347996359372800
https://www.researchgate.net/profile/Alvaro_Arjona-Sanchez 05-04-2016 13:47:44
5,5K Tweet
3,3K Takipçi
2,2K Takip Edilen
Paclitaxel-based HIPEC showed better outcomes than cisplatin, particularly for patients with a PCI of 15 or lower on this multicenter study, debate is open for Paclita as alternative to Cis Pedro Cascales SEOQ | Los cirujanos del cáncer #operarelcancer ESGO Peritoneal Surface Oncology Group International INDEPSO link.springer.com/article/10.124…